latest-issue-Nov-2018

Change and innovation in the pharma supply chain: more of the same in 2019?

content — Thu, 22 Nov 2018 06:40:29 +0000

2018 has seen some of the most fundamental changes to the pharmaceutical industry– driven by serialisation requirements in the US and EU, as there has been a seismic shift towards a more digitalised supply chain. The purpose of the respective laws – the Drug Supply Chain Security Act (DSCSA) and the Falsified Medicines Directive (FMD) […]

The post Change and innovation in the pharma supply chain: more of the same in 2019? first appeared on World Pharma Today.

Transforming The Life Sciences Supply Chain Through Blockchain

content — Thu, 22 Nov 2018 06:08:55 +0000

Imagine the Possibilities: What if innovations in the life sciences supply chain kept up with innovations in medicines and treatments? With many serialization and track & trace regulations in the compliance period, and others (e.g., EU FMD, US DSCSA) on the horizon, life sciences companies need to think beyond serialization as a core capability and […]

The post Transforming The Life Sciences Supply Chain Through Blockchain first appeared on World Pharma Today.

The need of innovation in the injectable business – a CDMO perspective

content — Thu, 22 Nov 2018 05:40:57 +0000

The world of drug development and manufacturing is undergoing a change. Nowhere is this more evident than in the rapid increase in complex compounds such as biologics. This change is further compounded with the erosion of the once commanding ‘blockbuster’ model. For pharmaceutical and biotechnology companies as well as the manufacturers that service them, innovation […]

The post The need of innovation in the injectable business – a CDMO perspective first appeared on World Pharma Today.

The importance of biometric functions to improving data quality in Clinical Trials

content — Thu, 22 Nov 2018 05:28:37 +0000

Reducing the costs associated with clinical trials is one of the pharmaceutical industry’s core challenges. Running a clinical trial is incredibly expensive and if a compound fails in the late phases, it can be catastrophic for its sponsor company. One of the areas where efficiencies can be found is in clinical data management systems and […]

The post The importance of biometric functions to improving data quality in Clinical Trials first appeared on World Pharma Today.

Speed, Quality and Cost – Leveraging Australia to Expedite Clinical Development

content — Thu, 22 Nov 2018 04:59:44 +0000

In recent years, the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market: being under increasing pressure to expedite the development of new therapies,to decrease clinical study duration, and to drive new treatments through their clinical phases as quickly, safely and cost-efficiently as possible. Such changes […]

The post Speed, Quality and Cost – Leveraging Australia to Expedite Clinical Development first appeared on World Pharma Today.

Capitalizing on Digital Innovation to Enhance Delivery

content — Thu, 22 Nov 2018 04:51:39 +0000

The 3 Ways Johnson & Johnson Is Capitalizing on Digital Innovation to Better Deliver Medicine to You? Janssen Supply Chain Vice President Remo Colarusso explains how the company is pioneering high-tech new strategies to perfect an age-old mandate: better anticipating and meeting customer demand—both now and in the future. Whenever you pop a pill to […]

The post Capitalizing on Digital Innovation to Enhance Delivery first appeared on World Pharma Today.

How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden of Data Collection

content — Thu, 22 Nov 2018 04:28:46 +0000

Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial physical and psychosocial consequences of the disease and its treatment and much of the symptom burden occurs outside the clinical environment. Oncology research is uniquely poised to benefit from both patient-reported outcomes and other clinical outcome assessment measures. Research suggests […]

The post How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden of Data Collection first appeared on World Pharma Today.

Looking Towards the Future: Worldwide Biosimilar Uptake and Pricing

content — Sat, 18 Aug 2018 00:58:58 +0000

What is a biosimilar? Whereas generic drugs are identical copycats of small-molecule chemical products, biosimilars are only similar to biologic products; innately more complex than chemical products, biologics are large-molecule, organic drugs, subject to natural variability and vulnerability due to climate changes during the manufacturing process, and as such, it is impossible to produce an […]

The post Looking Towards the Future: Worldwide Biosimilar Uptake and Pricing first appeared on World Pharma Today.